Quest 10 Wealth Builders’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
109
-2
-2% -$2.04K 0.1% 124
2026
Q1
$102K Buy
111
+29
+35% +$29.4K 0.09% 135
2025
Q4
$87.9K Hold
82
0.08% 140
2025
Q3
$62.4K Sell
82
-30
-27% -$22.3K 0.06% 162
2025
Q2
$87.2K Buy
112
+19
+20% +$14.8K 0.08% 137
2025
Q1
$76.7K Sell
93
-83
-47% -$69.1K 0.08% 139
2024
Q4
$136K Buy
+176
New +$146K 0.14% 114

Other funds holding LLY

Quest 10 Wealth Builders's LLY Position: Q2 2026 in Review

Quest 10 Wealth Builders reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $2.04K and leaving 109 shares worth $131K. The position accounts for 0.1% of the portfolio, ranked #124.

Quest 10 Wealth Builders first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $136K in Q4 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Quest 10 Wealth Builders held 109 shares of Eli Lilly worth $131K as of Q2 2026.
  • Quest 10 Wealth Builders sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.1% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #124 holding.
  • Quest 10 Wealth Builders first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Quest 10 Wealth Builders's Eli Lilly position peaked at $136K in Q4 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.